Several brokerages have updated their recommendations and price targets on shares of Healthcare Realty Trust (NYSE: HR) in the last few weeks:
- 5/14/2026 – Healthcare Realty Trust had its price target raised by Royal Bank Of Canada from $19.00 to $21.00. They now have a “sector perform” rating on the stock.
- 5/13/2026 – Healthcare Realty Trust had its price target raised by UBS Group AG from $18.00 to $20.00. They now have a “buy” rating on the stock.
- 5/8/2026 – Healthcare Realty Trust had its price target raised by Scotiabank from $20.00 to $22.00. They now have an “outperform” rating on the stock.
- 5/7/2026 – Healthcare Realty Trust had its price target raised by Citigroup Inc. from $19.00 to $21.00. They now have a “neutral” rating on the stock.
- 5/4/2026 – Healthcare Realty Trust was downgraded by Weiss Ratings from “hold (c)” to “sell (d+)”.
- 5/4/2026 – Healthcare Realty Trust had its price target raised by Cantor Fitzgerald from $21.00 to $22.00. They now have an “overweight” rating on the stock.
- 4/20/2026 – Healthcare Realty Trust is now covered by UBS Group AG. They set a “neutral” rating and a $18.00 price target on the stock.
- 3/27/2026 – Healthcare Realty Trust had its “hold (c)” rating reaffirmed by Weiss Ratings.
Healthcare Realty Trust Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 22nd. Stockholders of record on Monday, May 11th will be issued a $0.24 dividend. This represents a $0.96 annualized dividend and a dividend yield of 4.7%. The ex-dividend date of this dividend is Monday, May 11th. Healthcare Realty Trust’s payout ratio is -165.52%.
Insider Activity at Healthcare Realty Trust
In related news, Director Thomas N. Bohjalian bought 10,000 shares of the company’s stock in a transaction that occurred on Friday, March 6th. The shares were purchased at an average cost of $18.09 per share, with a total value of $180,900.00. Following the completion of the acquisition, the director directly owned 85,520 shares in the company, valued at approximately $1,547,056.80. The trade was a 13.24% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.56% of the stock is owned by insiders.
Healthcare Realty Trust (NYSE: HR) is a real estate investment trust specializing in the ownership, acquisition and management of outpatient medical facilities. Headquartered in Nashville, Tennessee, the company’s portfolio is focused primarily on medical office buildings and outpatient healthcare properties that serve hospitals, health systems and other healthcare providers. Its business model centers on securing long-term, triple-net leases to generate stable income streams from a diversified tenant base.
The company’s properties are located across key metropolitan markets in the United States, including major healthcare hubs in the Southeast, Southwest and in select coastal regions.
Featured Articles
- Five stocks we like better than Healthcare Realty Trust
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Receive News & Ratings for Healthcare Realty Trust Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.
